Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Varenicline for Vaping Cessation in Adolescents
NCT05367492Phase 4Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jun 2022
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of varenicline in nicotine dependence, sponsored by Massachusetts General Hospital. Started Jun 2022; status: completed.
02
Drugs
varenicline
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT05367492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05367492.